| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | 0.095 | 0.01 |
| mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.071 | 0.01 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.01 |
| mRNA | triazolothiadiazine | CTRPv2 | pan-cancer | AAC | 0.073 | 0.01 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.088 | 0.01 |
| mRNA | JW-55 | CTRPv2 | pan-cancer | AAC | -0.18 | 0.01 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.01 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.089 | 0.01 |
| mRNA | THZ-2-102-1 | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | 0.085 | 0.02 |